Public Data
8 samples
IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in MV3 (total RNA)]
Accession: SRP252425
Published: 2020 in Nucleic Acids Res
cell line
control, sirna
zone of skin
melanoma
Public Data
6 samples
IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in HepG2 (polyA RNA)]
Accession: SRP252414
Published: 2020 in Nucleic Acids Res
cell line
control, sirna
liver
liver cancer
Public Data
6 samples
IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in A549 (polyA RNA)]
Accession: SRP251876
Published: 2020 in Nucleic Acids Res
cell line
control, sirna
lung
lung cancer
Public Data
6 samples
IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KO in A-549 (polyA RNA)]
Accession: SRP251874
Published: 2020 in Nucleic Acids Res
cell line
control, crispr
lung
lung cancer
Public Data
20 samples
Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734
Accession: SRP238472
Published: 2020 in Mol Cancer Ther
cell line, other
compound, control
thoracic cavity
nut midline carcinoma
Public Data
6 samples
Transcriptomic Characterization of LIPA+/+ and LIPA-/- iPSC-derived Macrophages
Accession: SRP109815
Published: 2020 in Arterioscler Thromb Vasc Biol
primary cells
control, crispr
macrophage
Public Data
17 samples
Transcriptional profiles of human mature B cells from tonsil tissue
Accession: SRP227968
Published: 2020 in J Exp Med
primary cells
tonsil
Public Data
66 samples
Selective therapeutic targeting of the first and second bromodomains of the BET proteins in cancer and immuno-inflammation [SLAM-seq]
Accession: SRP223772
Published: 2020 in Science
cell line
compound, compound, ...
blood, macrophage, ...
erythroleukemia, leukemia
Public Data
24 samples
Selective therapeutic targeting of the first and second bromodomains of the BET proteins in cancer and immuno-inflammation [RNA-seq]
Accession: SRP223454
Published: 2020 in Science
primary cells
compound, compound, ...
blood
Public Data
4 samples
TET1 is a tumour suppressor that inhibits bladder cancer progression
Accession: SRP222326
Published: 2020 in Front Oncol
cell line
control, overexpression
bladder cell
bladder dome cancer
Public Data
12 samples
NRF2 is a key regulator of endothelial miRNA expression under pro-atherogenic stimuli
Accession: SRP220198
Published: 2020 in Cardiovasc Res
primary cells
compound, control
aorta, umbilical vein
Public Data
31 samples
Induced pluripotent stem cells of patients with Tetralogy of Fallot reveal transcriptional alterations in cardiomyocyte differentiation
Accession: SRP133643
Published: 2020 in Sci Rep
cell line, primary cells
in_vitro_differentiated
tetralogy of fallot
Public Data
10 samples
A highly efficient KRAB domain for CRISPRi applications
Accession: SRP268081
Published: 2020
cell line
control, overexpression
kidney
Public Data
10 samples
RNA-seq to investigate effect miRNA 210 knockdown of airway respiratory muscle cells treated with BEAS-2B cell condition media
Accession: ERP122243
Published: 2020
primary cells
other
respiratory system smooth muscle
normal
Public Data
80 samples
Expression analysis of human ex vivo cultivated urothelial carcinoma samples transduced with a trivalent adenoviral vector (Im02) for activation of the immune tumor microenvironment.
Accession: ERP113699
Published: 2020
primary tissue
urothelium
urothelial carcinoma